FATAL TRANSFUSION-ASSOCIATED GRAFT-VERSUS-HOST DISEASE IN THE PATIENT AFTER AORTOCORONARY BYPASS (Clinical case)
Goal: to demonstrate the rare case of transfusion-associated graft-versus-host disease (TA-GvHD) after transfusion of blood components. The cause of TA-GvHD is implantation of donor lymphocytes, contained in blood components, which is related to immunological HLA-homology between the donor and recip...
| Main Authors: | , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
New Terra Publishing House
2018-01-01
|
| Series: | Вестник анестезиологии и реаниматологии |
| Subjects: | |
| Online Access: | https://www.vair-journal.com/jour/article/view/118 |
| _version_ | 1797700391229456384 |
|---|---|
| author | O. V. Goloschapov M. A. Estrina N. E. Ivanova I. M. Barkhatov A. D. Kulagin S. N. Bondarenko I. S. Moiseev I. V. Shlyk Yu. S. Polushin B. V. Afanasiev |
| author_facet | O. V. Goloschapov M. A. Estrina N. E. Ivanova I. M. Barkhatov A. D. Kulagin S. N. Bondarenko I. S. Moiseev I. V. Shlyk Yu. S. Polushin B. V. Afanasiev |
| author_sort | O. V. Goloschapov |
| collection | DOAJ |
| description | Goal: to demonstrate the rare case of transfusion-associated graft-versus-host disease (TA-GvHD) after transfusion of blood components. The cause of TA-GvHD is implantation of donor lymphocytes, contained in blood components, which is related to immunological HLA-homology between the donor and recipient, that does not eliminate the donor cells. Mortality makes 90-100%. 68 year old patient had planned surgery - aortocoronary bypass. In the post-operative period under pressure anemia three doses of unirradiated packed red blood cells were transfused. On the 17th day after transfusion the patient developed febrile fever and manifested erythematous cutaneous rush. On the 24th day after transfusion neutropenia developed. Evaluation results of allele discrimination of high-polymorphic markers confirmed the diagnosis of TA-GvHD. HLA-typing of the donor's and recipient's blood was done retrospectively. The donor was homozygous in five loci in low resolution and in loci of HLA-А*, HLA-В*, HLA-DRB1* he had the gene common with the patient. On the 34th day after the transfusion the patient died of infectious complications. X-ray or gamma-irradiation of blood components in order to inactivate the donor's viable T-lymphocytes is considered to be the only way to guarantee the prevention of TA-GvHD. Since there is no effective therapy for TA-GvHD, prevention of risk to develop the disease, strict indications to blood transfusions and capacity for early diagnosis become crucial. |
| first_indexed | 2024-03-12T04:21:06Z |
| format | Article |
| id | doaj.art-9f13bb91e2f04164981feb9f99a4ebd5 |
| institution | Directory Open Access Journal |
| issn | 2078-5658 2541-8653 |
| language | Russian |
| last_indexed | 2024-03-12T04:21:06Z |
| publishDate | 2018-01-01 |
| publisher | New Terra Publishing House |
| record_format | Article |
| series | Вестник анестезиологии и реаниматологии |
| spelling | doaj.art-9f13bb91e2f04164981feb9f99a4ebd52023-09-03T10:33:17ZrusNew Terra Publishing HouseВестник анестезиологии и реаниматологии2078-56582541-86532018-01-01135505710.21292/2078-5658-2016-13-5-50-57118FATAL TRANSFUSION-ASSOCIATED GRAFT-VERSUS-HOST DISEASE IN THE PATIENT AFTER AORTOCORONARY BYPASS (Clinical case)O. V. Goloschapov0M. A. Estrina1N. E. Ivanova2I. M. Barkhatov3A. D. Kulagin4S. N. Bondarenko5I. S. Moiseev6I. V. Shlyk7Yu. S. Polushin8B. V. Afanasiev9ФГБОУ «Первый Санкт-Петербургский государственный медицинский университет им. акад. И. П. Павлова» Минздрава России, Санкт- ПетербургФГБОУ «Первый Санкт-Петербургский государственный медицинский университет им. акад. И. П. Павлова» Минздрава России, Санкт- ПетербургФГБОУ «Первый Санкт-Петербургский государственный медицинский университет им. акад. И. П. Павлова» Минздрава России, Санкт- ПетербургФГБОУ «Первый Санкт-Петербургский государственный медицинский университет им. акад. И. П. Павлова» Минздрава России, Санкт- ПетербургФГБОУ «Первый Санкт-Петербургский государственный медицинский университет им. акад. И. П. Павлова» Минздрава России, Санкт- ПетербургФГБОУ «Первый Санкт-Петербургский государственный медицинский университет им. акад. И. П. Павлова» Минздрава России, Санкт- ПетербургФГБОУ «Первый Санкт-Петербургский государственный медицинский университет им. акад. И. П. Павлова» Минздрава России, Санкт- ПетербургФГБОУ «Первый Санкт-Петербургский государственный медицинский университет им. акад. И. П. Павлова» Минздрава России, Санкт- ПетербургФГБОУ «Первый Санкт-Петербургский государственный медицинский университет им. акад. И. П. Павлова» Минздрава России, Санкт- ПетербургФГБОУ «Первый Санкт-Петербургский государственный медицинский университет им. акад. И. П. Павлова» Минздрава России, Санкт- ПетербургGoal: to demonstrate the rare case of transfusion-associated graft-versus-host disease (TA-GvHD) after transfusion of blood components. The cause of TA-GvHD is implantation of donor lymphocytes, contained in blood components, which is related to immunological HLA-homology between the donor and recipient, that does not eliminate the donor cells. Mortality makes 90-100%. 68 year old patient had planned surgery - aortocoronary bypass. In the post-operative period under pressure anemia three doses of unirradiated packed red blood cells were transfused. On the 17th day after transfusion the patient developed febrile fever and manifested erythematous cutaneous rush. On the 24th day after transfusion neutropenia developed. Evaluation results of allele discrimination of high-polymorphic markers confirmed the diagnosis of TA-GvHD. HLA-typing of the donor's and recipient's blood was done retrospectively. The donor was homozygous in five loci in low resolution and in loci of HLA-А*, HLA-В*, HLA-DRB1* he had the gene common with the patient. On the 34th day after the transfusion the patient died of infectious complications. X-ray or gamma-irradiation of blood components in order to inactivate the donor's viable T-lymphocytes is considered to be the only way to guarantee the prevention of TA-GvHD. Since there is no effective therapy for TA-GvHD, prevention of risk to develop the disease, strict indications to blood transfusions and capacity for early diagnosis become crucial.https://www.vair-journal.com/jour/article/view/118посттрансфузионная реакция трансплантат против хозяинааортокоронарное шунтированиеискусственное кровообращениеhla-типированиегамма-облучениерентгеновское облучение компонентов кровиоценка аллельной дискриминации высокополиморфных маркеров |
| spellingShingle | O. V. Goloschapov M. A. Estrina N. E. Ivanova I. M. Barkhatov A. D. Kulagin S. N. Bondarenko I. S. Moiseev I. V. Shlyk Yu. S. Polushin B. V. Afanasiev FATAL TRANSFUSION-ASSOCIATED GRAFT-VERSUS-HOST DISEASE IN THE PATIENT AFTER AORTOCORONARY BYPASS (Clinical case) Вестник анестезиологии и реаниматологии посттрансфузионная реакция трансплантат против хозяина аортокоронарное шунтирование искусственное кровообращение hla-типирование гамма-облучение рентгеновское облучение компонентов крови оценка аллельной дискриминации высокополиморфных маркеров |
| title | FATAL TRANSFUSION-ASSOCIATED GRAFT-VERSUS-HOST DISEASE IN THE PATIENT AFTER AORTOCORONARY BYPASS (Clinical case) |
| title_full | FATAL TRANSFUSION-ASSOCIATED GRAFT-VERSUS-HOST DISEASE IN THE PATIENT AFTER AORTOCORONARY BYPASS (Clinical case) |
| title_fullStr | FATAL TRANSFUSION-ASSOCIATED GRAFT-VERSUS-HOST DISEASE IN THE PATIENT AFTER AORTOCORONARY BYPASS (Clinical case) |
| title_full_unstemmed | FATAL TRANSFUSION-ASSOCIATED GRAFT-VERSUS-HOST DISEASE IN THE PATIENT AFTER AORTOCORONARY BYPASS (Clinical case) |
| title_short | FATAL TRANSFUSION-ASSOCIATED GRAFT-VERSUS-HOST DISEASE IN THE PATIENT AFTER AORTOCORONARY BYPASS (Clinical case) |
| title_sort | fatal transfusion associated graft versus host disease in the patient after aortocoronary bypass clinical case |
| topic | посттрансфузионная реакция трансплантат против хозяина аортокоронарное шунтирование искусственное кровообращение hla-типирование гамма-облучение рентгеновское облучение компонентов крови оценка аллельной дискриминации высокополиморфных маркеров |
| url | https://www.vair-journal.com/jour/article/view/118 |
| work_keys_str_mv | AT ovgoloschapov fataltransfusionassociatedgraftversushostdiseaseinthepatientafteraortocoronarybypassclinicalcase AT maestrina fataltransfusionassociatedgraftversushostdiseaseinthepatientafteraortocoronarybypassclinicalcase AT neivanova fataltransfusionassociatedgraftversushostdiseaseinthepatientafteraortocoronarybypassclinicalcase AT imbarkhatov fataltransfusionassociatedgraftversushostdiseaseinthepatientafteraortocoronarybypassclinicalcase AT adkulagin fataltransfusionassociatedgraftversushostdiseaseinthepatientafteraortocoronarybypassclinicalcase AT snbondarenko fataltransfusionassociatedgraftversushostdiseaseinthepatientafteraortocoronarybypassclinicalcase AT ismoiseev fataltransfusionassociatedgraftversushostdiseaseinthepatientafteraortocoronarybypassclinicalcase AT ivshlyk fataltransfusionassociatedgraftversushostdiseaseinthepatientafteraortocoronarybypassclinicalcase AT yuspolushin fataltransfusionassociatedgraftversushostdiseaseinthepatientafteraortocoronarybypassclinicalcase AT bvafanasiev fataltransfusionassociatedgraftversushostdiseaseinthepatientafteraortocoronarybypassclinicalcase |